SGLT2 inhibitors-induced electrolyte abnormalities: An analysis of the associated mechanisms. (Record no. 27483707)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01284 a2200349 4500 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250517171124.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 201809s 0 0 eng d |
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
International Standard Serial Number | 1878-0334 |
024 7# - OTHER STANDARD IDENTIFIER | |
Standard number or code | 10.1016/j.dsx.2017.08.003 |
Source of number or code | doi |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | NLM |
Language of cataloging | eng |
Transcribing agency | NLM |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Filippatos, T D |
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
Date of production, publication, distribution, manufacture, or copyright notice | 20180912 |
245 00 - TITLE STATEMENT | |
Title | SGLT2 inhibitors-induced electrolyte abnormalities: An analysis of the associated mechanisms. |
Medium | [electronic resource] |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Diabetes & metabolic syndrome |
Date of publication, distribution, etc. | |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 59-63 p. |
Other physical details | digital |
500 ## - GENERAL NOTE | |
General note | Publication Type: Journal Article; Review |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Benzhydryl Compounds |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Canagliflozin |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Diabetes Mellitus, Type 2 |
General subdivision | drug therapy |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Electrolytes |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Glucosides |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Humans |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Hypoglycemic Agents |
General subdivision | therapeutic use |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Metabolic Diseases |
General subdivision | blood |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sodium-Glucose Transporter 2 |
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
Topical term or geographic name entry element | Sodium-Glucose Transporter 2 Inhibitors |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Tsimihodimos, V |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Liamis, G |
700 1# - ADDED ENTRY--PERSONAL NAME | |
Personal name | Elisaf, M S |
773 0# - HOST ITEM ENTRY | |
Title | Diabetes & metabolic syndrome |
Related parts | vol. 12 |
-- | no. 1 |
-- | p. 59-63 |
856 40 - ELECTRONIC LOCATION AND ACCESS | |
Uniform Resource Identifier | <a href="https://doi.org/10.1016/j.dsx.2017.08.003">https://doi.org/10.1016/j.dsx.2017.08.003</a> |
Public note | Available from publisher's website |
No items available.